贵州省ICU重症患者镇痛与镇静的评估和管理现状
该研究为回顾性研究,利用2021年4月至6月贵州省非省级公立综合ICU医院质控活动数据,纳入145家医院947例ICU重症患者。入ICU 24小时内接受疼痛评估者312例(32.9%)、躁动评估者277例(29.3%);疼痛评估工具中CPOT占44.2%(138/312),三级医院使用率52.3%(69/132)高于二级医院38.3%(69/180),P<0.05;躁动评估中RASS占93.8%(260/277)。592例(62.5%)接受静脉镇痛药,瑞芬太尼最常用(42.9%,254/592);510例(53.9%)接受静脉镇静药,咪达唑仑最常用(60.8%,310/510)。机械通气与低血压与镇痛镇静药物使用相关。
要点
- 入ICU 24小时内疼痛评估率仅32.9%(312/947)、躁动评估率仅29.3%(277/947),规范化评估比例较低。
- 疼痛评估工具中CPOT占44.2%(138/312);三级医院CPOT使用率52.3%(69/132)高于二级医院38.3%(69/180),P<0.05。
- 躁动评估中RASS占93.8%(260/277),二级与三级医院间无显著差异。
- 机械通气患者镇痛药使用率77.9%(451/579)高于非机械通气患者38.8%(137/353),镇静药使用率71.8%(416/579)高于25.8%(91/353),均P<0.05。
- 低血压患者镇痛药使用率74.7%(183/245)高于非低血压患者59.8%(345/577),镇静药使用率65.7%(161/245)高于51.3%(296/577),均P<0.05。
适用人群与场景
- 2021年4月至6月贵州省非省级公立医院综合ICU的成年重症患者,调查当日收治于综合ICU者,共947例,来自145家医院(二级医院104家、三级医院41家)。
处置流程与药物剂量
- 镇痛药物:入ICU 24小时内592例(62.5%)接受静脉镇痛药,最常用瑞芬太尼(42.9%,254/592)。
- 镇静药物:入ICU 24小时内510例(53.9%)接受静脉镇静药,最常用咪达唑仑(60.8%,310/510)。
- 机械通气患者中,镇痛药选择强阿片类者占85.8%(95/137),非机械通气患者为69.3%(387/451),P<0.05。
- 机械通气患者镇静以咪达唑仑为主(66.6%,277/416),非机械通气患者更多使用右美托咪定(45.1%,41/91)。
研究设计与关键结果
- 研究类型:回顾性研究,利用2021年4月至6月贵州省质控活动数据;样本量947例,来自145家医院(二级104家、三级41家)。
- 主要结果:入ICU 24小时内疼痛评估312例(32.9%),躁动评估277例(29.3%)。
- 疼痛评估工具:CPOT占44.2%(138/312);三级医院52.3%(69/132)vs 二级医院38.3%(69/180),P<0.05;RASS用于躁动评估占93.8%(260/277),医院级别间无显著差异。
- 药物使用:静脉镇痛药592例(62.5%),瑞芬太尼最常用42.9%(254/592);静脉镇静药510例(53.9%),咪达唑仑最常用60.8%(310/510)。
- 机械通气(932例有数据):579例(62.1%)机械通气,353例(37.9%)未机械通气;机械通气患者镇痛药77.9%(451/579)vs 非机械通气38.8%(137/353),镇静药71.8%(416/579)vs 25.8%(91/353),均P<0.05。
- 低血压(822例有数据):245例(29.8%)低血压,577例(70.2%)无低血压;低血压患者镇痛药74.7%(183/245)vs 59.8%(345/577),镇静药65.7%(161/245)vs 51.3%(296/577),均P<0.05;两组镇痛或镇静药物选择无显著差异。
证据类型、等级与局限
- 证据类型:回顾性研究,利用贵州省质控活动数据。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文结论指出贵州省ICU重症患者接受规范化疼痛和躁动评估的比例相对较低。
- 原文结论指出最常用的评估工具为CPOT和RASS,最常用的镇痛药和镇静药分别为瑞芬太尼和咪达唑仑。
- 原文结论指出二级医院规范化疼痛评估工具使用率低于三级医院。
- 原文结论指出机械通气与低血压与镇痛镇静药物使用相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the current status of early pain and agitation management in critically ill patients in Guizhou Province.
METHODS: A retrospective study was performed using data collected from a quality control activity conducted between April and June 2021 in non-provincial public hospitals with general intensive care unit (ICU) in Guizhou Province. Hospital-level data included hospital name and grade, ICU staffing, and number of ICU beds. Patient-level data included characteristics of patients treated in the general ICU on the day of the survey (e.g., age, sex, primary diagnosis), as well as pain and agitation assessments and the types of analgesic and sedative medications administered within 24 hours of ICU admission.
RESULTS: A total of 947 critically ill ICU patients from 145 hospitals were included, among which 104 were secondary-level hospitals and 41 were tertiary-level hospitals. Within 24 hours of ICU admission, 312 (32.9%) critically ill patients received pain assessments, and 277 (29.3%) received agitation assessments. Among the pain assessment tools, the critical care pain observation tool (CPOT) was used in 44.2% (138/312) of critically ill ICU patients, with a significantly higher usage rate in tertiary hospitals compared to secondary hospitals [52.3% (69/132) vs. 38.3% (69/180), P < 0.05]. The Richmond agitation-sedation scale (RASS) was used in 93.8% (260/277) of critically ill ICU patients for agitation assessment, with no significant difference between hospital levels. Among the 947 critically ill patients, 592 (62.5%) received intravenous analgesics within 24 hours, with remifentanil being the most commonly used [42.9% (254/592)]; 510 (53.9%) received intravenous sedatives, with midazolam being the most frequently used [60.8% (310/510)]. Mechanical ventilation data were available for 932 critically ill patients, of whom 579 (62.1%) received mechanical ventilation and 353 (37.9%) did not. Compared with non-ventilated patients, ventilated patients had significantly higher rates of analgesic and sedative use [analgesics: 77.9% (451/579) vs. 38.8% (137/353); sedatives: 71.8% (416/579) vs. 25.8% (91/353); both P < 0.05]. In terms of analgesic selection, ventilated patients were more likely to receive strong opioids than non-ventilated patients [85.8% (95/137) vs. 69.3% (387/451), P < 0.05]. For sedatives, ventilated patients preferred midazolam [66.6% (277/416)], whereas non-ventilated patients more often received dexmedetomidine [45.1 (41/91)]. Blood pressure within 24 hours of ICU admission were available for 822 critically ill patients, of whom 245 (29.8%) had hypotension and 577 (70.2%) did not. Compared with non-hypotensive patients, hypotensive patients had significantly higher rates of analgesic and sedative use [analgesics: 74.7% (183/245) vs. 59.8% (345/577); sedatives: 65.7% (161/245) vs. 51.3% (296/577); both P < 0.05], but there was no significant difference in the choice of analgesic or sedative agents between the two groups.
CONCLUSIONS: The proportion of critically ill ICU patients in Guizhou Province who received standardized pain and agitation assessments was relatively low. The most commonly used assessment tools were CPOT and RASS, while remifentanil and midazolam were the most frequently used analgesic and sedative agents, respectively. Secondary-level hospitals had a lower rate of using standardized pain assessment tools compared to tertiary-level hospitals. Mechanical ventilation and hypotension were associated with the use of analgesic and sedative medications.
参考来源
- Wei Y, Zhang Q, Bi H, et al. [Assessment and management of analgesic and sedation in critically ill patients from ICU in Guizhou Province]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 41146509. doi:10.3760/cma.j.cn121430-20240723-00624
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。